Patents by Inventor Marc W. Fariss

Marc W. Fariss has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD OF MAKING STABILIZED TOBACCO PRODUCT
    Publication number: 20230397651
    Abstract: The method includes adding at least one first chelator to smokeless tobacco in an amount effective to reduce an amount of free calcium in the smokeless tobacco by 20% or more and reduce an amount of free iron in the smokeless tobacco by 60% or more.
    Type: Application
    Filed: August 18, 2023
    Publication date: December 14, 2023
    Applicant: Altria Client Services LLC
    Inventors: Marc W. FARISS, Jeffery EDMISTON, Dongmei XU, Randall BAREN, Yahya KARGALIOGLU, James A. STRICKLAND
  • Method of treating smokeless tobacco
    Patent number: 11766068
    Abstract: The method includes first adding at least one first chelator to smokeless tobacco, second adding at least one first antioxidant to the smokeless tobacco, the at least one first antioxidant being different than the at least one first chelator, and third adding at least one first flavorant to the smokeless tobacco, wherein the first adding occurs before the third adding.
    Type: Grant
    Filed: March 9, 2020
    Date of Patent: September 26, 2023
    Assignee: Altria Client Services LLC
    Inventors: Marc W. Fariss, Jeffery Edmiston, Dongmei Xu, Randall Baren, Yahya Kargalioglu, James A. Strickland
  • METHODS AND SYSTEMS FOR IMPROVING STABILITY OF PRE-VAPOR FORMULATIONS OF E-VAPING DEVICES
    Publication number: 20180220697
    Abstract: A pre-vapor formulation that may be included in an e-vaping device may include a solvent and a solution compound. The solvent may include one or more of propylene glycol and glycerin. The solution compound may include one of a saccharide compound, a salt compound, and a polyethylene compound. The concentration of the solution compound may be between about 0.2% and about 10%.
    Type: Application
    Filed: February 3, 2017
    Publication date: August 9, 2018
    Applicant: Altria Client Services LLC
    Inventors: Marc W. FARISS, Michael J. OLDHAM
  • METHODS AND SYSTEMS FOR INCREASING STABILITY OF THE PRE-VAPOR FORMULATION OF AN E-VAPING DEVICE
    Publication number: 20180103681
    Abstract: A pre-vapor formulation of an e-vaping device including a vapor former configured to form a vapor, nicotine, at least one or more ion exchangers, one or more chelating agents and optionally acids. The one or more ion exchangers include Dowex 50W-X8, Lewait CNP 80 or Amberlite IR-120. The pre-vapor formulation may also include chelating agents such as EDTA, DTPA and NTA. The concentration of the ion exchangers may be between about 0.1% and about 5% and the concentration of the chelating agents may be between about 0.001% and 0.05%.
    Type: Application
    Filed: October 18, 2016
    Publication date: April 19, 2018
    Applicant: Altria Client Services LLC
    Inventor: Marc W. FARISS
  • METHODS AND SYSTEMS FOR IMPROVING STABILITY OF THE PRE-VAPOR FORMULATION OF AN E-VAPING DEVICE
    Publication number: 20180103680
    Abstract: A pre-vapor formulation of an e-vaping device including a vapor former configured to form a vapor, nicotine, at least one polyol compound and optionally at least one of more acids. The at least one polyol compound comprises at least one of mannitol, erythritol, xylithol and sorbitol. The pre-vapor formulation may also include chelating agents such as EDTA, DTPA and NTA. The concentration of the polyol compounds may be between about 0.2% and about 10% and the concentration of the chelating agents may be between about 0.001% and 0.05%.
    Type: Application
    Filed: October 18, 2016
    Publication date: April 19, 2018
    Applicant: Altria Client Services LLC
    Inventor: Marc W. FARISS
  • Ionizable congeners of aromatic and aliphatic alcohols as anti-leukemia agents
    Patent number: 5610180
    Abstract: Ionizable congeners of aromatic and aliphatic alcohols provide potent cytoprotective properties in vivo and in vitro. Alpha-tocopherol succinate, cholesteryl succinate, cholesteryl sulfate, dihydrocholesterol succinate, dihydrocholesterol sulfate, and ergosterol analogs are particularly good cytoprotective agents. In addition, the tris salts of these compounds have superior cytoprotective properties.
    Type: Grant
    Filed: August 8, 1994
    Date of Patent: March 11, 1997
    Assignee: Virginia Commonwealth University
    Inventor: Marc W. Fariss
  • Method for protecting animals against tacrine induced cytotoxic injury using sterol compounds
    Patent number: 5336485
    Abstract: Ionizable congeners of aromatic and aliphatic alcohols provide potent cytoprotective properties in vivo and in vitro. Alpha-tocopherol succinate, cholesteryl succinate, cholesteryl sulfate, dihydrocholesterol succinate, dihydrocholesterol sulfate, and ergosterol analogs are particularly good cytoprotective agents. In addition, the tris salts of these compounds have superior cytoprotective properties.
    Type: Grant
    Filed: March 10, 1993
    Date of Patent: August 9, 1994
    Assignees: Center for Innovative Technology, Virginia Commonwealth University
    Inventor: Marc W. Fariss
  • Method of preventing chlorohydrocarbon toxicity using sterol derivatives
    Patent number: 5198432
    Abstract: Ionizable congeners of aromatic and aliphatic alcohols provide potent cytoprotective properties in vivo and in vitro. Alpha-tocopherol succinate, cholesteryl succinate, cholesteryl sulfate, dihydrocholesterol succinate, dihydrocholesterol sulfate, and ergosterol analogs are particularly good cytoprotective agents. In addition, the tris salts of these compounds have superior cytoprotective properties.
    Type: Grant
    Filed: April 1, 1991
    Date of Patent: March 30, 1993
    Assignees: Center for Innovative Technology, Virginia Commonwealth University
    Inventor: Marc W. Fariss